Long term impact of antiretroviral therapy--can we end HIV epidemic, the goal beyond 2015.
作者信息
Kumarasamy N, Pendse R
机构信息
YRGCARE Medical Centre, Voluntary Health Services, Chennai 600 113, Tamil Nadu, India.
出版信息
Indian J Med Res. 2014 Dec;140(6):701-3.
Abstract
摘要
相似文献
1
Long term impact of antiretroviral therapy--can we end HIV epidemic, the goal beyond 2015.抗逆转录病毒疗法的长期影响——我们能否终结艾滋病流行，这是2015年后的目标。
Indian J Med Res. 2014 Dec;140(6):701-3.
2
A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy.在高效抗逆转录病毒治疗时代，男男性行为者中HIV-1疫情再度抬头。
AIDS. 2008 May 31;22(9):1071-7. doi: 10.1097/QAD.0b013e3282fd167c.
3
Early antiretroviral therapy and better care retention can reduce HIV/AIDS epidemic in India.早期抗逆转录病毒治疗和更好的治疗依从性可以减少印度的艾滋病毒/艾滋病疫情。
Natl Med J India. 2015 Nov-Dec;28(6):314.
4
Antiretroviral pre-exposure prophylaxis: A new opportunity to slow HIV spread in India.抗逆转录病毒暴露前预防：减缓印度艾滋病毒传播的新机遇。
Indian J Med Res. 2016 Feb;143(2):125-8. doi: 10.4103/0971-5916.180194.
5
Dean Street clinics-battling London's MSM HIV epidemic.迪恩街诊所——对抗伦敦男男性行为者中的艾滋病流行
Lancet HIV. 2018 May;5(5):e210. doi: 10.1016/S2352-3018(18)30070-5. Epub 2018 May 1.
6
Ending the HIV Epidemic in the United States.终结美国的艾滋病疫情。
Am J Nurs. 2020 Mar;120(3):21-22. doi: 10.1097/01.NAJ.0000656304.84951.da.
7
HIV End the Epidemic in the South: The Importance of Measuring Progression to AIDS and Death.终结美国南部地区的艾滋病流行：衡量进展至艾滋病及死亡情况的重要性
Am J Public Health. 2019 Sep;109(9):1159-1160. doi: 10.2105/AJPH.2019.305251.
8
Modelling the impact of antiretroviral therapy on the epidemic of HIV.模拟抗逆转录病毒疗法对艾滋病毒流行的影响。
Curr HIV Res. 2011 Sep;9(6):367-82. doi: 10.2174/157016211798038533.
9
Prevalence of HIV-1 Drug Resistance among Patients with Antiretroviral Therapy Failure in Sichuan, China, 2010-2016.2010 - 2016年中国四川省抗逆转录病毒治疗失败患者中HIV - 1耐药性的流行情况
Tohoku J Exp Med. 2019 Jan;247(1):1-12. doi: 10.1620/tjem.247.1.
10
Is HAART modifying the HIV epidemic?高效抗逆转录病毒疗法正在改变艾滋病毒的流行状况吗？
Lancet. 2010 Aug 14;376(9740):492-3. doi: 10.1016/S0140-6736(10)61057-4. Epub 2010 Jul 16.
引用本文的文献
1
HIV-related stigma trends in the general population of India during an era of antiretroviral treatment expansion, 2005-16.抗逆转录病毒治疗扩展时代印度一般人群中与艾滋病毒相关的耻辱趋势，2005-2016 年。
J Glob Health. 2020 Dec;10(2):020420. doi: 10.7189/jogh.10.020420.
2
The Convergence of Disclosure Concerns and Poverty Contributes to Loss to HIV Care in India: A Qualitative Study.披露问题和贫困的融合导致印度艾滋病毒护理的损失：一项定性研究。
J Int Assoc Provid AIDS Care. 2020 Jan-Dec;19:2325958220934606. doi: 10.1177/2325958220934606.
3
Association between internalized stigma and depression among HIV-positive persons entering into care in Southern India.印度南部接受治疗的HIV阳性患者内化耻辱感与抑郁之间的关联。
J Glob Health. 2017 Dec;7(2):020403. doi: 10.7189/jogh.07.020403.
本文引用的文献
1
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries.中低收入国家开始联合抗逆转录病毒治疗时的免疫缺陷。
J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):e8-16. doi: 10.1097/QAI.0b013e3182a39979.
2
Transmitted drug resistance and antiretroviral treatment outcomes in non-subtype B HIV-1-infected patients in South East Asia.东南亚非 B 型 HIV-1 感染患者的传播耐药和抗逆转录病毒治疗结果。
J Acquir Immune Defic Syndr. 2014 May 1;66(1):74-9. doi: 10.1097/QAI.0000000000000108.
3
Clinical impact and cost-effectiveness of expanded voluntary HIV testing in India.印度扩大自愿艾滋病毒检测的临床影响和成本效益。
PLoS One. 2013 May 31;8(5):e64604. doi: 10.1371/journal.pone.0064604. Print 2013.
4
Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era.巴西里约热内卢 HIV 感染患者死亡率变化：抗逆转录病毒治疗时代，艾滋病相关疾病死亡向非艾滋病相关疾病转变。
PLoS One. 2013;8(4):e59768. doi: 10.1371/journal.pone.0059768. Epub 2013 Apr 5.
5
Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings.三种抗逆转录病毒方案治疗 HIV-1 初治的疗效和安全性：多种族多国环境下的随机临床试验。
PLoS Med. 2012;9(8):e1001290. doi: 10.1371/journal.pmed.1001290. Epub 2012 Aug 14.
6
Determinants of HIV drug resistance and public health implications in low- and middle-income countries.低收入和中等收入国家中艾滋病毒耐药性的决定因素及其对公共卫生的影响
Antivir Ther. 2012;17(6):941-53. doi: 10.3851/IMP2320. Epub 2012 Aug 16.
7
Prevention of HIV-1 infection with early antiretroviral therapy.早期抗逆转录病毒疗法预防 HIV-1 感染。
N Engl J Med. 2011 Aug 11;365(6):493-505. doi: 10.1056/NEJMoa1105243. Epub 2011 Jul 18.
8
Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial.肯尼亚移动电话短信服务对艾滋病病毒治疗依从性的影响（WelTel Kenya1）：一项随机试验。
Lancet. 2010 Nov 27;376(9755):1838-45. doi: 10.1016/S0140-6736(10)61997-6. Epub 2010 Nov 9.
9
Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India.替诺福韦作为一线抗逆转录病毒治疗在印度的成本效益。
Clin Infect Dis. 2010 Feb 1;50(3):416-25. doi: 10.1086/649884.
10
High frequency of clinically significant mutations after first-line generic highly active antiretroviral therapy failure: implications for second-line options in resource-limited settings.一线通用高效抗逆转录病毒治疗失败后具有临床意义的突变的高频率：对资源有限环境中二线治疗方案的影响。
Clin Infect Dis. 2009 Jul 15;49(2):306-9. doi: 10.1086/600044.
Zotero 插件